Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 54 results.
User Information
Export Records
  1. 1.   Solution Properties of Murine Leukemia Virus Gag Protein: Differences from HIV-1 Gag
  2. Datta, S. A. K.; Zuo, X. B.; Clark, P. K.; Campbell, S. J.; Wang, Y. X.; Rein, A.
  3. Journal of Virology. 2011, Dec; 85(23): 12733-12741.
  1. 2.   The substrate specificity of Metarhizium anisopliae and Bos taurus carboxypeptidases A: Insights into their use as tools for the removal of affinity tags
  2. Austin, B. P.; Tozser, J.; Bagossi, P.; Tropea, J. E.; Waugh, D. S.
  3. Protein Expression and Purification. 2011, May; 77(1): 53-61.
  1. 3.   Gag Localization and Virus-Like Particle Release Mediated by the Matrix Domain of Human T-Lymphotropic Virus Type 1 Gag Are Less Dependent on Phosphatidylinositol-(4,5)-Bisphosphate than Those Mediated by the Matrix Domain of HIV-1 Gag
  2. Inlora, J.; Chukkapalli, V.; Derse, D.; Ono, A.
  3. Journal of Virology. 2011, Apr; 85(8): 3802-3810.
  1. 4.   Myristate Exposure in the Human Immunodeficiency Virus Type 1 Matrix Protein Is Modulated by pH
  2. Fledderman, E. L.; Fujii, K.; Ghanam, R. H.; Waki, K.; Prevelige, P. E.; Freed, E. O.; Saad, J. S.
  3. Biochemistry. 2010, Nov; 49(44): 9551-9562.
  1. 5.   Impact of synchrotron radiation on macromolecular crystallography: a personal view
  2. Dauter, Z.; Jaskolski, M.; Wlodawer, A.
  3. Journal of Synchrotron Radiation. 2010, Jul; 17: 433-444.
  1. 6.   Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton
  2. Barkan, D.; Kleinman, H.; Simmons, J. L.; Asmussen, H.; Kamaraju, A. K.; Hoenorhoff, M. J.; Liu, Z. Y.; Costes, S. V.; Cho, E. H.; Lockett, S.; Khanna, C.; Chambers, A. F.; Green, J. E.
  3. Cancer Research. 2008 68(15): 6241-6250.
  1. 7.   Structure and activity of Yersinia pestis 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase as a novel target for the development of antiplague therapeutics
  2. Blaszczyk, J.; Li, Y.; Cherry, S.; Alexandratos, J.; Wu, Y.; Shaw, G.; Tropea, J. E.; Waugh, D. S.; Yan, H. G.; Ji, X. H.
  3. Acta Crystallographica Section D-Biological Crystallography. 2007, Nov; 63: 1169-1177.
  1. 8.   Stereochemical restraints revisited: how accurate are refinement targets and how much should protein structures be allowed to deviate from them?
  2. Jaskolski, M.; Gilski, M.; Dauter, Z.; Wlodawer, A.
  3. Acta Crystallographica Section D-Biological Crystallography. 2007, May; 63: 611-620.
  1. 9.   An insight into the sialome of the oriental rat flea, Xenopsylla cheopis (Rots)
  2. Andersen, J. F.; Hinnebusch, B. J.; Lucas, D. A.; Conrads, T. P.; Veenstra, T. D.; Pham, V. M.; Ribeiro, J. M. C.
  3. Bmc Genomics. 2007, Apr; 8
  1. 10.   A second-site suppressor significantly improves the defective phenotype impolsed by mutation of an aromatic residue in the N-terminal domain of the HIV-1 capsid protein
  2. Tang, S. X.; Ablan, S.; Dueck, M.; Ayala-Lopez, W.; Soto, B.; Caplan, M.; Nagashima, K.; Hewlett, I. K.; Freed, E. O.; Levin, J. G.
  3. Virology. 2007, Mar; 359(1): 105-115.
  1. 11.   Conformation of the HIV-1 Gag protein in solution
  2. Datta, S. A. K.; Curtis, J. E.; Ratcliff, W.; Clark, P. K.; Crist, R. M.; Lebowitz, J.; Krueger, S.; Rein, A.
  3. Journal of Molecular Biology. 2007, Jan; 365(3): 812-824.
  1. 12.   Purification, crystallization and preliminary X-ray diffraction of human S100A15
  2. Boeshans, K. M.; Wolf, R.; Voscopoulos, C.; Gillette, W.; Esposito, D.; Mueser, T. C.; Yuspa, S. H.; Ahvazi, B.
  3. Acta Crystallographica Section F-Structural Biology and Crystallization Communications. 2006, May; 62: 467-470.
  1. 13.   Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs
  2. Prabakaran, P.; Gan, J. H.; Wu, Y. Q.; Zhang, M. Y.; Dimitrov, D. S.; Ji, X. H.
  3. Journal of Molecular Biology. 2006, MAR 17; 357(1): 82-99.
  1. 14.   Structural and dynamical classification of RNA single-base bulges for nanostructure design
  2. Hastings, W. A.; Yingling, Y. G.; Chirikjian, G. S.; Shapiro, B. A.
  3. Journal of Computational and Theoretical Nanoscience. 2006, FEB; 3(1): 63-77.
  1. 15.   Structure and dynamics of micelle-associated human immunodeficiency virus gp41 fusion domain
  2. Jaroniec, C. P.; Kaufman, J. D.; Stahl, S. J.; Viard, M.; Blumenthal, R.; Wingfield, P. T.; Bax, A.
  3. Biochemistry. 2005, DEC 13; 44(49): 16167-16180.
  1. 16.   Inhibition of pathologic retinal neovascularization by alpha-defensins
  2. Economopoulou, M.; Bdeir, K.; Cines, D. B.; Fogt, F.; Bdeir, Y.; Lubkowski, J.; Lu, W. Y.; Preissner, K. T.; Hammes, H. P.; Chavakis, T.
  3. Blood. 2005, DEC 1; 106(12): 3831-3838.
  1. 17.   Structural basis for the function of stringent starvation protein A as a transcription factor
  2. Hansen, A. M.; Gu, Y. J.; Li, M.; Andrykovitch, M.; Waugh, D. S.; Jin, D. J.; Ji, X. H.
  3. Journal of Biological Chemistry. 2005, APR 29; 280(17): 17380-17391.
  1. 18.   Solution structure of the cyclotide palicourein: Implications for the development of a pharmaceutical framework
  2. Barry, D. G.; Daly, N. L.; Bokesch, H. R.; Gustafson, K. R.; Craik, D. J.
  3. Structure. 2004 12(1): 85-94.
  1. 19.   Completely automated, highly error-tolerant macromolecular structure determination from multidimensional nuclear overhauser enhancement spectra and chemical shift assignments
  2. Kuszewski, J.; Schwieters, C. D.; Garrett, D. S.; Byrd, R. A.; Tjandra, N.; Clore, G. M.
  3. Journal of the American Chemical Society. 2004 126(20): 6258-6273.
  1. 20.   Predicting molecular interactions in silico: I. A guide to pharmacophore identification and its applications to drug design
  2. Dror, O.; Shulman-Peleg, A.; Nussinov, R.; Wolfson, H. J.
  3. Current Medicinal Chemistry. 2004 11(1): 71-90.
  1. 21.   X-ray snapshots of the maturation of an antibody response to a protein antigen
  2. Li, Y. L.; Li, H. M.; Yang, F.; Smith-Gill, S. J.; Mariuzza, R. A.
  3. Nature Structural Biology. 2003 10(6): 482-488.
  1. 22.   An unusual orientation for Tyr75 in the active site of the aspartic proteinase from Saccharomyces cerevisiae
  2. Gustchina, A.; Li, M.; Phylip, L. H.; Lees, W. E.; Kay, J.; Wlodawer, A.
  3. Biochemical and Biophysical Research Communications. 2002 295(4): 1020-1026.
  1. 23.   The structure of human macrophage inflammatory protein-3 alpha/CCL20 - Linking antimicrobial and CC chemokine receptor- 6-binding activities with human beta-defensins
  2. Hoover, D. M.; Boulegue, C.; Yang, D.; Oppenheim, J. J.; Tucker, K.; Lu, W. Y.; Lubkowski, J.
  3. Journal of Biological Chemistry. 2002 277(40): 37647-37654.
  1. 24.   Structure-based design of AIDS drugs and the development of resistance
  2. Wlodawer, A.
  3. Vox Sanguinis. 2002 83(Suppl. 1): 23-26.
  1. 25.   Crystal structure of paprika ferredoxin-NADP(+) reductase - Implications for the electron transfer pathway
  2. Dorowski, A.; Hofmann, A.; Steegborn, C.; Boicu, M.; Huber, R.
  3. Journal of Biological Chemistry. 2001 276(12): 9253-9263.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel